This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Assistance Publique-Hopitaux De Paris, Université Paris Descartes. Active years: 2006-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,853 
1 out of 331 
1 out of 132 
Years Active: 2006-2018
Title: Lucienne Chatenoud: Innovator in Allergy and Autoimmune Disease Research
Introduction: Lucienne Chatenoud is a distinguished inventor based in Paris, France, renowned for her contributions to the fields of immunology and allergy research. With an impressive portfolio that includes two patents, her work has greatly influenced diagnostic and therapeutic approaches for allergic and autoimmune diseases.
Latest Patents: Lucienne's latest patents include significant advancements in medical science. The first patent focuses on the identification of IL-4 and/or IL-13 secreting T-cells as biomarkers for allergic diseases. This invention enables the in vitro use of these specific T-cells for the diagnosis and monitoring of IgE-dependent allergic diseases, offering a promising pathway for enhanced patient care. The second patent discusses a method for treating established spontaneous autoimmune diseases in mammals. This method involves administering a therapeutically effective amount of non-mitogenic anti-CD3 active principles to achieve permanent disease remission through the induction of antigen-specific unresponsiveness, essentially promoting immune tolerance.
Career Highlights: Throughout her career, Lucienne Chatenoud has made significant strides in medical research and innovation. Her roles at reputable institutions such as the National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale) and the University of Paris Descartes highlight her commitment to advancing science and improving health outcomes.
Collaborations: Lucienne has collaborated with esteemed colleagues, including Jean-François Bach and Jocelyne Just, further amplifying the impact of her research through shared expertise and collective efforts in the field of immunology.
Conclusion: Lucienne Chatenoud stands as a pivotal figure in the realm of medical research, particularly in allergy and autoimmune disease treatment. Her innovative approach and dedication to her work continue to inspire future developments and pave the way for new therapeutic solutions. Her contributions not only enhance scientific understanding but also hold the potential to improve the lives of many patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile